A Phase IV Open Label Investigation of the Efficacy and Durability of Once Daily Antiretroviral Therapy With Kaletra [lopinavir/ritonavir] and Viread [tenofovir] in Antiretroviral Naive Patients
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2012
At a glance
- Drugs Lopinavir/ritonavir; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 19 Sep 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Jun 2008 New trial record.